Literature DB >> 8573287

Lymphocyte adhesion to endothelium.

U Dianzani1, F Malavasi.   

Abstract

The different homing and recirculation behaviors of lymphocytes depend on expression of specific adhesion receptors by lymphocytes and endothelial cells. Expression of these receptors is finely regulated according to cell type, functional state, and anatomical location, and builds up a complex network of interactions that simultaneously involve several of these receptors working as "traffic signals" or "postcodes" for lymphocyte migration and homing. There are five main families of adhesion molecules: immunoglobulin superfamily, integrins, selectins, cadherins, and mucin-like molecules. Together with these "classified" receptors, other molecules, such as CD44 and CD38, have been shown to be involved in lymphocyte migration and homing. Leukocytes have evolved a intracellular system that allows them to maintain these receptors in an inactive state during transit in the bloodstream and extracellular-fluids and activate them only when proper specific stimuli are delivered. This activity has been called "inside-out" signaling. Most receptor/ligand systems regulating lymphocyte migration are not selectively dedicated to this function. They are involved in lymphocyte interaction with several cell types and play a key role in both the afferent and efferent branches of immune responses by mediating lymphocyte interaction with APC and target cells. They not only "passively" anchor lymphocytes to these cells but also exert an active "outside-in" signaling function that modulates the cell response to activation stimuli. In this review, we briefly describe the major features of these molecules, survey what is known about their role in lymphocyte/endothelium interactions both in vitro and in vivo, and discuss their possible therapeutical application.

Entities:  

Mesh:

Year:  1995        PMID: 8573287     DOI: 10.1615/critrevimmunol.v15.i2.40

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  17 in total

1.  Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Phosphatidylserine-mediated adhesion of T-cells to endothelial cells.

Authors:  J Qu; L A Conroy; J H Walker; F B Wooding; J A Lucy
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Immunophenotypic comparison of heterogenous non-sorted versus sorted mononuclear cells from human umbilical cord blood: a novel cell enrichment approach.

Authors:  S Indumathi; R Harikrishnan; J S Rajkumar; M Dhanasekaran
Journal:  Cytotechnology       Date:  2013-12-20       Impact factor: 2.058

4.  Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation.

Authors:  E Savilahti; T Ormälä; T Saukkonen; U Sandini-Pohjavuori; J M Kantele; A Arato; J Ilonen; H K Akerblom
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

5.  Intercellular communication in the immune system: differential expression of connexin40 and 43, and perturbation of gap junction channel functions in peripheral blood and tonsil human lymphocyte subpopulations.

Authors:  E Oviedo-Orta; T Hoy; W H Evans
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

6.  Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Authors:  R Minelli; L Serpe; P Pettazzoni; V Minero; G Barrera; Cl Gigliotti; R Mesturini; A C Rosa; P Gasco; N Vivenza; E Muntoni; R Fantozzi; U Dianzani; G P Zara; C Dianzani
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.

Authors:  F Messud-Petit; J Gelfi; M Delverdier; M F Amardeilh; R Py; G Sutter; S Bertagnoli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 8.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

9.  Activated T-lymphocytes express occludin, a component of tight junctions.

Authors:  J S Alexander; T Dayton; C Davis; S Hill; T H Jackson; O Blaschuk; M Symonds; N Okayama; C G Kevil; F S Laroux; S M Berney; D Kimpel
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

Review 10.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.